Account

New to ADSS? Open an
account now to get started.

OR

Already have an account?

Add funds to your ADSS account

Account

New to ADSS? Open an
account now to get started.

Add funds to your ADSS account

Trends & Analysis
News

British pound continues last week’s downtrend

News

Is Microsoft too cheap to ignore?

News

US dollar surges to 7-week high on NFP data

News

Shares of Levi Strauss tumble amid weak sales

News

Crude oil breaches $70 amid geopolitical concerns

News

Will silver soar to $35?

Trends & Analysis
News

British pound continues last week’s downtrend

News

Is Microsoft too cheap to ignore?

News

US dollar surges to 7-week high on NFP data

News

Shares of Levi Strauss tumble amid weak sales

News

Crude oil breaches $70 amid geopolitical concerns

News

Will silver soar to $35?

Pfizer (PFE) – Introduction and background

Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.

Pfizer, Inc. is an American pharmaceutical and biotechnology corporation. It discovers, develops, manufacturers, markets, and sells biopharmaceutical products worldwide, and it was a key player in the development and distribution of the COVID-19 vaccine.

Pfizer Share Price Today

Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.

Founded in 1849, Pfizer offers vaccines, biosimilars, and anti-infective medicines under various brands, including but not limited to Eliquis, Nimenrix, Comirnaty, Vyndaqel, Genotropin, and Sulperazon. The corporation is also involved in the contract manufacturing business, serving wholesalers, retailers, hospitals, government agencies, and more.

Pfizer became a publicly traded company in June 1942, with its 5.9 million USD IPO becoming one of the largest of that year. In 1998, the company’s market capitalisation had grown by more than a million percent from its IPO valuation, and by 2004, it was indisputably the largest company among its peers worldwide. In 2020, Pfizer’s share price saw astronomical growth with the company’s involvement in the development of the COVID-19 vaccine. However, it has since tailed off as demand drops off for COVID treatments.

Why trade equities with ADSS?

Competitive prices

Enjoy highly competitive CFD pricing across global markets.

Every market’s waiting

Trade CFDs globally and locally across asset classes.

Enhanced trading experience

Benefit from using our comprehensive and customisable trading platform.

Related equities

Platform

Your new trading adventure starts today

Discover our intuitive, next-generation trading platform


Site by Pink Green
© ADSS 2024


Investing in CFDs involves a high degree of risk that you will lose your money due to the use of leverage, particularly in fast moving markets, where a relatively small movement in the price can lead to a proportionately larger movement in the value of your investment. This can result in loses that exceed the funds in your account. You should consider whether you understand how CFDs work and you should seek independent advice if necessary.

ADS Securities LLC (“ADSS”) is authorised and regulated by the Securities and Commodities Authority (“SCA”) in the United Arab Emirates as a trading broker for Over the Counter (“OTC”) Derivatives contracts and foreign exchange spot markets. ADSS is a limited liability company incorporated under United Arab Emirates law. The company is registered with the Department of Economic Development of Abu Dhabi (No. 1190047) and has its principal place of business at 8th Floor, CI Tower, Corniche Road, P.O. Box 93894, Abu Dhabi, United Arab Emirates.

The information presented is not directed at residents of any particular country outside the United Arab Emirates and is not intended for distribution to, or use by, any person in any country where the distribution or use is contrary to local law or regulation.

ADSS is an execution only service provider and does not provide advice. ADSS may publish general market commentary from time to time. Where it does, the material published does not constitute advice, or a solicitation, or a recommendation to a transaction in any financial instrument. ADSS accepts no responsibility for any use of the content presented and any consequences of that use. No representation or warranty is given as to the completeness of this information. Anyone acting on the information provided does so at their own risk.